{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:42:25Z","timestamp":1791520945915,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Ministry of Health"},{"name":"Amici del Bambino Malato"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.vaccine.2011.11.083","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T17:19:26Z","timestamp":1323364766000},"page":"936-940","source":"Crossref","is-referenced-by-count":49,"title":["Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis"],"prefix":"10.1016","volume":"30","author":[{"given":"Laura","family":"Dell\u2019Era","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Daleno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Principi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.11.083_bib0005","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/ker102","article-title":"Vaccination of children and adolescents with rheumatic diseases","volume":"50","author":"Dell\u2019Era","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/QCO.0b013e32832a58e4","article-title":"The rational use of influenza vaccines in healthy children and children with underlying conditions","volume":"22","author":"Esposito","year":"2009","journal-title":"Curr Opin Infect Dis"},{"issue":"RR-8","key":"10.1016\/j.vaccine.2011.11.083_bib0015","first-page":"1","article-title":"Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/rheumatology\/41.8.937","article-title":"Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence","volume":"41","author":"Davies","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0025","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/587063","article-title":"Vaccination in patients with chronic rheumatic or autoimmune diseases","volume":"46","author":"Gl\u0171ck","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2008.07.007","article-title":"Vaccination and autoimmune rheumatic diseases","volume":"8","author":"Conti","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0035","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0040","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/kel366","article-title":"Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis","volume":"46","author":"Kapetanovic","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0045","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2007.077552","article-title":"The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination","volume":"67","author":"Gelinck","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.25033","article-title":"Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab","volume":"62","author":"van Assen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0055","first-page":"1769","article-title":"Influenza immunization in children with chronic arthritis: a prospective study","volume":"20","author":"Malleson","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0060","first-page":"1581","article-title":"Influenza immunization in children with chronic arthritis","volume":"21","author":"Olson","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0065","first-page":"589","article-title":"Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy","volume":"19","author":"Kanakoudi-Tsakalidou","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/INF.0b013e3181f7ce44","article-title":"Immunogenicity of influenza vaccine in children with pediatric rheumatic diseases receiving immunosuppressive agents","volume":"30","author":"Ogimi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0075","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0080","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.vaccine.2008.01.019","article-title":"Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses","volume":"26","author":"Ansaldi","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0085","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.vaccine.2009.01.078","article-title":"Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients","volume":"27","author":"Setti","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0090","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jmv.20559","article-title":"Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T cell activation in HIV-infected children receiving highly active antiretroviral therapy","volume":"78","author":"Tanzi","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0095","unstructured":"European Agency for the Evaluation of Medicinal Products (EMEA) \u2013 Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonization of requirements for influenza vaccines (CPMP\/BWP\/214\/96). London, March 12, 1997."},{"key":"10.1016\/j.vaccine.2011.11.083_bib0100","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00006454-200404000-00005","article-title":"Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children","volume":"23","author":"Kanra","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0105","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1517\/14712591003724662","article-title":"MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk","volume":"10","author":"Durando","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0110","doi-asserted-by":"crossref","first-page":"e1161","DOI":"10.1542\/peds.2010-1920","article-title":"Influenza A\/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months","volume":"127","author":"Esposito","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0115","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1517\/14712598.2011.562495","article-title":"Present and future of influenza prevention in pediatrics","volume":"11","author":"Principi","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/INF.0b013e31819d6394","article-title":"Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0125","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1016\/j.vaccine.2009.02.004","article-title":"MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination","volume":"27","author":"Vesikari","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0130","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1016\/j.vaccine.2010.09.058","article-title":"Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A\/H1N1 MF59-adjuvanted vaccine in patients with \u03b2-thalassemia major","volume":"28","author":"Esposito","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0135","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/gfq657","volume":"26","author":"Esposito","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0140","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4161\/hv.7.6.15133","article-title":"Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A\/H1N1 MF59-adjuvanted vaccine in children and adolescents with Williams or Cornelia De Lange syndrome","volume":"7","author":"Esposito","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2011.08.012","article-title":"Different influenza vaccine formulations and adjuvants for childhood influenza vaccination","author":"Esposito","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/ard.2005.036434","article-title":"Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF\u03b1 blockers","volume":"65","author":"Fomin","year":"2006","journal-title":"Ann Rheuma Dis"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clim.2009.09.014","article-title":"Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNF\u03b1 blockers: safety and immunogenicity","volume":"134","author":"Salemi","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2011.11.083_bib0160","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2008.120","article-title":"Immune response to influenza vaccine in children with inflammatory bowel disease","volume":"104","author":"Lu","year":"2009","journal-title":"Am J Gastroenterol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11018792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11018792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T02:58:17Z","timestamp":1543373897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11018792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0264410X11018792"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}